| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,529 |
1,392 |
$112K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,833 |
1,574 |
$84K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
763 |
668 |
$27K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
166 |
146 |
$24K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
635 |
532 |
$18K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,142 |
1,018 |
$18K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
279 |
243 |
$11K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
464 |
408 |
$11K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
111 |
111 |
$9K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
98 |
90 |
$7K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
89 |
84 |
$4K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
77 |
62 |
$3K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
29 |
29 |
$937.60 |
| 81002 |
|
79 |
72 |
$203.43 |
| 81025 |
|
26 |
24 |
$130.80 |
| 81003 |
|
21 |
14 |
$44.04 |